Glyoxylate Reductase/Hydroxypyruvate Reductase: A Novel Prognostic Marker for Hepatocellular Carcinoma Patients after Curative Resection

Publisher： Karger

E-ISSN： 1423-0291|80|3|155-162

ISSN： 1015-2008

Source： Pathobiology, Vol.80, Iss.3, 2013-03, pp. : 155-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinicopathological Features and Metastatic Pattern of Hepatocellular Carcinoma: An Autopsy Study of 398 Patients

By  

Pathobiology, Vol. 83, Iss. 6, 2016-06 ,pp. : 301-307

Karger

Access to resources Recommend Favorite

PRO_10 – A New Tissue-Based Prognostic Multigene Marker in Patients with Early Estrogen Receptor-Positive Breast Cancer

By  

Pathobiology, Vol. 78, Iss. 3, 2011-05 ,pp. : 140-148

Karger

Access to resources Recommend Favorite

Overexpression of Cyclooxygenase-2 Is Associated with a Favorable Prognostic Phenotype in Breast Carcinoma

By  

Pathobiology, Vol. 72, Iss. 5, 2005-12 ,pp. : 241-249

Karger

Access to resources Recommend Favorite

Prolyl Hydroxylase Domain 2 Protein Is a Strong Prognostic Marker in Human Gastric Cancer

By  

Pathobiology, Vol. 79, Iss. 1, 2012-01 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Hepatocellular and Cholangiolar Carcinoma-Derived Cell Lines Reveal Distinct Sets of Chromosomal Imbalances

By  

Pathobiology, Vol. 79, Iss. 3, 2012-01 ,pp. : 115-126

Karger

Access to resources Recommend Favorite